Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
FDA grants orphan drug designation to Cellspan esophageal implant
The FDA has issued orphan drug designation to Biostage’s Cellspan esophageal implant, which restores the structure and function of the esophagus following damage related to cancer, injury or congenital abnormalities, the company announced.
F. nucleatum associated with poor survival in esophageal cancer
The presence of Fusobacterium nucleatum in cancer tissue appeared associated with shorter survival in patients with esophageal cancer, according to results of a study conducted in Japan.
Log in or Sign up for Free to view tailored content for your specialty!
V Foundation presents grants to Vanderbilt researchers
The V Foundation for Cancer Research presented 2-year grant awards to two Vanderbilt-Ingram Cancer Center investigators.
Y90 radioembolization delays time to HCC progression vs. TACE
In a phase 2 clinical trial, the use of yttrium-90 radioembolization was more effective in prolonging time to tumor progression vs. conventional transarterial chemoembolization in patients with early intermediate hepatocellular carcinoma.
Sessile serrated polyps share risk factors with conventional adenomas
Some of the same modifiable lifestyle factors associated with the risk for developing conventional adenomas are also associated with the risk for sessile serrated polyps, according to a study led by researchers from Vanderbilt University School of Medicine.
PPIs may be linked to fundic gland polyps, gastric cancer
Use of proton pump inhibitors for at least a year was associated with an increased risk for fundic gland polyps, according to a systematic review and meta-analysis.
Rutgers Cancer Institute of New Jersey names new director
Steven K. Libutti , MD, FACS, has been appointed director of Rutgers Cancer Institute of New Jersey.
Prediagnostic wine consumption may slightly improve colorectal cancer survival outcomes
Higher levels of prediagnostic wine consumption may be associated with slightly improved survival in patients with colorectal cancer, according to a study published in Cancer.
FDA grants priority review to Keytruda for microsatellite instability–high cancers
The FDA granted priority review to the anti–PD-1 therapy pembrolizumab for use in previously treated patients with advanced microsatellite instability–high cancers, according to the agent’s manufacturer.
Financial incentives fail to improve colorectal cancer screening
Offering $5 or $10 as an incentive for responding to a mailed invitation to undergo a fecal immunochemical test had no effect on colorectal cancer screening rates, according to a study published in “The Negative Issue” of the American Journal of Gastroenterology, a special edition focusing on what physicians should not do in clinical practice.
-
Headline News
Wrong positioning for BP screening could overestimate measurements
October 14, 20242 min read -
Headline News
Oral bacteria may be biomarker to predict risk for head, neck cancers
October 14, 20243 min read -
Headline News
Secondary melanoma risk highest in Black patients
October 11, 20242 min read
-
Headline News
Wrong positioning for BP screening could overestimate measurements
October 14, 20242 min read -
Headline News
Oral bacteria may be biomarker to predict risk for head, neck cancers
October 14, 20243 min read -
Headline News
Secondary melanoma risk highest in Black patients
October 11, 20242 min read